[HT-07] ホットトピックス07 Innovative management can bring bright future for Parkinson's disease

[HT-07-3] HALを使用したサイバニクス治療の適応を神経筋疾患からパーキンソン病へ拡大するための探索的研究

^○中島 孝¹, 松井 彩乃^2,5, 坂本 崇³, 西田 大輔^4,5 (1.国立病院機構新潟病院 脳神経内科, 2.国立精神・神経医療研究センター　総合外科部 整形外科, 3.国立精神・神経医療研究センター　脳神経内科, 4.国立精神・神経医療研究センター　リハビリテーション科, 5.国立病院機構新潟病院　リハビリテーション科)

Dr.Takashi Nakajima, MD, Ph.D., is a Neurologist and the Director of the National Hospital Organization Niigata National Hospital. He graduated from Niigata Univ. School of Medicine (1983). He became a resident and a research fellow of the Brain Research Institute, Niigata Univ. (1983-1984), and he completed the Ph.D. program of Niigata Univ. (1985-1991). He joined the National Institute of Mental Health, NIH (USA) as a Fogarty Fellow (1987-1989). He was an expert member of the Pharmaceutical, Medical Device and Food Committee, MHLW (2001-2004). Since 2004, he has been a guest lecturer of the Brain Research Institute, Niigata Univ., and a specialist of PMDA. His main research areas are Neurology, Neuro-rehabilitation, PRO, and Clinical Trial Design. He is a member of various medical societies, including the Japanese Society of Neurology (Specialist, Instructor), the Japan Society for Dementia Research (Specialist), and the Japanese Society for Genetic Counselling (Specialist).